340 related articles for article (PubMed ID: 30444340)
1. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
[TBL] [Abstract][Full Text] [Related]
3. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
[TBL] [Abstract][Full Text] [Related]
5. Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
Kang X; Wang J; Huang CH; Wibowo FS; Amin R; Chen P; Li F
Nanomedicine; 2023 Jan; 47():102620. PubMed ID: 36265559
[TBL] [Abstract][Full Text] [Related]
6. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
McMahon A; Chen W; Li F
J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelin-based PEGylation Cu (DDC)
Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
[TBL] [Abstract][Full Text] [Related]
8. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the accumulation of disulfiram and its copper complex in A549 cells using mass spectrometry.
Lu X; Lin B; Xu N; Huang H; Wang Y; Lin JM
Talanta; 2020 May; 211():120732. PubMed ID: 32070566
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
11. Nanoscale Copper(II)-Diethyldithiocarbamate Coordination Polymer as a Drug Self-Delivery System for Highly Robust and Specific Cancer Therapy.
Peng Y; Liu P; Meng Y; Hu S; Ding J; Zhou W
Mol Pharm; 2020 Aug; 17(8):2864-2873. PubMed ID: 32551674
[TBL] [Abstract][Full Text] [Related]
12. The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)
Liu H; Kong Y; Liang X; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
Expert Opin Drug Deliv; 2023 Jan; 20(1):145-158. PubMed ID: 36462209
[TBL] [Abstract][Full Text] [Related]
13. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
14. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
15. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
16. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca
Guo Z; Gao X; Lu J; Li Y; Jin Z; Fahad A; Pambe NU; Ejima H; Sun X; Wang X; Xie W; Zhang G; Zhao L
ACS Nano; 2024 Mar; 18(9):6975-6989. PubMed ID: 38377439
[TBL] [Abstract][Full Text] [Related]
19. Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Zhang T; Kephart J; Bronson E; Anand M; Daly C; Spasojevic I; Bakthavatsalam S; Franz K; Berg H; Karachaliou GS; James OG; Howard L; Halabi S; Harrison MR; Armstrong AJ; George DJ
Prostate; 2022 May; 82(7):858-866. PubMed ID: 35286730
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin intercalated copper diethyldithiocarbamate functionalized layered double hydroxide hybrid nanoparticles for targeted therapy of hepatocellular carcinoma.
Xu Y; Kong Y; Xu J; Li X; Gou J; Yin T; He H; Zhang Y; Tang X
Biomater Sci; 2020 Feb; 8(3):897-911. PubMed ID: 31825410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
